gastric cancer
Dr. Travis Grotz discusses how hyperthermic intraperitoneal chemotherapy (HIPEC) works and the potential benefits of the treatment.
Mayo Clinic study shows a new approach to chemotherapy more than doubles the typical survival rate for people with stomach cancer.
Dr. Travis Grotz, a Mayo Clinic surgical oncologist, explains the symptoms, diagnosis and treatment of stomach cancer.
Researchers have identified a gene biomarker associated with overall survival and treatment response in people with gastric cancer.
The story of 39-year-old Stacy Weisensel's diagnosis of stomach cancer and her treatment journey at Mayo Clinic.
Researchers are investigating whether immunotherapy benefits people with esophageal and gastric cancers that have not spread to distant organs.
A study is validating the use of genomic sequencing to predict the likelihood that patients with gastric cancer will derive benefit from therapies.
During Stomach Cancer Awareness Month, recognized in November, learn about this disease and the symptoms and risk factors that could help you stay alert.